1. Home
  2. INCY
  3. INCY News

Latest Incyte Corp. (INCY) News on October 25, 2025

Incyte Announces New 24-Week Phase 3 Data from the STOP-HS Clinical Trial Program of Povorcitinib in Hidradenitis Suppurativa at EADV 2025

Business Wire

a month ago

Incyte Announces New 24-Week Phase 3 Data from the STOP-HS Clinical Trial Program of Povorcitinib in Hidradenitis Suppurativa at EADV 2025

Morningstar Research

5 months ago

Analyst Report: Incyte Corporation

Argus Research

5 months ago

Analyst Report: Incyte Corp.

Thomson Reuters StreetEvents

6 months ago

Q1 2025 Syndax Pharmaceuticals Inc Earnings Call

Share on Social Networks: